CNO Q1 2026 Earnings Call Summary

CNO Financial Group, Inc. Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

Operating Earnings: Increased 33% to $1.05 per diluted share; up 42% excluding significant items.
Sales Growth: Achieved fifteenth consecutive quarter of sales growth; total new annualized premiums rose 11%.
Book Value: Book value per diluted share (excluding AOCI) increased 5% to $38.98.
Expense Ratio: Recorded at 18.9%, lower than planned, with expectations for normalization throughout the year.
Return on Equity (ROE): Operating ROE at 13.1%, 12.2% excluding significant items.

2. Strategic Updates and Business Highlights

Consumer Division: Strong performance with Life and Health new annualized premiums (NAP) up 9% and total Health NAP up 20%. Medicare policies sold increased by 24%, with Medicare supplement NAP up 53%.
Worksite Division: Life and Health NAP rose 22%, marking sixteenth consecutive quarters of sales growth. Life insurance sales surged 56%.
Agent Growth: Producing agent count grew by 3%, marking thirteenth consecutive quarters of growth.
Technology Investments: Enhanced customer experience and agent productivity through AI and technology initiatives, including improvements in call center operations.

3. Forward Guidance and Outlook

2026 Guidance: Affirmed original guidance; management remains optimistic about business performance despite macroeconomic volatility. Plans to refine projections later in the year.
ROE Targets: Management indicated potential increases in ROE ambitions for 2027, emphasizing ongoing improvements beyond the current 12% target.

4. Challenges and Points of Concern

Medicare Supplement Claims: Noted an increase in claims leading to higher benefit ratios; management plans to implement rate increases to address this.
Annuity Sales: Collected premiums down 2% due to tough comparisons from the previous year, raising concerns about sustaining growth in this segment.
Market Volatility: Credit market fluctuations and economic uncertainty pose risks, although management remains disciplined in investment strategies.

5. Notable Q&A Insights

Medicare Supplement Pricing: Management discussed planned rate increases for both closed and open blocks, with expectations for improved benefit ratios by Q4 2026.
Expense Management: Clarified that favorable expense results in Q1 were not expected to continue, but growth in the business should help maintain a favorable expense ratio.
Investment Strategy: Emphasized a cautious approach to new investments amidst market volatility, with a focus on maintaining high-quality assets and capital efficiency.

Overall, CNO Financial Group demonstrated strong performance in Q1 2026, with significant growth in sales and earnings, while also addressing challenges in specific product lines and navigating a volatile economic landscape.

CNO — CNO Financial Group, Inc.